Categories: News

EssilorLuxottica: Full-Year 2024 Results Conference Call Invitation

Full-Year 2024 Results
Conference Call Invitation

Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer,
Mr PAUL DU SAILLANT, Deputy Chief Executive Officer,
Mr STEFANO GRASSI, Chief Financial Officer, and
Mr GIORGIO IANNELLA, Head of Investor Relations,
have the pleasure of inviting you to our Full-Year 2024 Results Conference Call on:

Wednesday, February 12, 2025, at 6:30 pm CET

Dial-in telephone access:

If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID):

https://grid.trustwavetechnology.com/essilorluxottica/register.html

If you encounter any issue in the pre-registration phase you may contact ir@essilorluxottica.com, providing your name and surname and the name of your company.

Live webcast:

You can watch the presentation at the following link:

https://streamstudio.world-television.com/1217-2090-41194/en

The press release will be published at 6:00 pm CET on the same day and the presentation slides will be made available prior to the call. Both can be found on https://www.essilorluxottica.com/investors.

Attachment

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

21 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

21 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

21 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

21 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

21 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

21 hours ago